Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Califf

Showing results (71-80 of 567) with videos related to

Pageof 57
Sort By:
Journal of the American College of Cardiology|April 1, 1987
Medical approaches to prevention of restenosis after coronary angioplastyJ L Blackshear, W G O'Callaghan, R M Califf
Circulation|December 13, 1997
Trials in myocardial infarctionE M Ohman, R M Califf, E J Topol
Clinical Pharmacology and Therapeutics|July 17, 2007
Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeuticsH H Tilson, L K Madre, R M Califf
Circulation|September 1, 1991
Clinical trials of restenosis after coronary angioplastyJ J Popma, R M Califf, E J Topol
Drugs|September 1, 1992
Thrombolytic therapy for acute myocardial infarction. A review C B Granger, R M Califf, E J Topol
The British Journal of Clinical Practice|November 1, 1993
The irony of biased editors who write editorials. GUSTO InvestigatorsE J Topol, R M Califf, K L Lee
Annals of Internal Medicine|June 1, 1994
The last word on GUSTO, for nowK L Lee, R M Califf, E J Topol
Journal of the American College of Cardiology|November 1, 1989
From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapyR M Califf, E J Topol, B J Gersh
Journal of the American College of Cardiology|April 12, 2000
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery diseaseA M Lincoff, R M Califf, E J Topol
Circulation|November 1, 1990
Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trialsR M Califf, L Harrelson-Woodlief, E J Topol
Pageof 57

Showing results (71-80 of 567) with videos related to

Sort By:
Pageof 57
Journal of the American College of Cardiology|April 1, 1987
Medical approaches to prevention of restenosis after coronary angioplastyJ L Blackshear, W G O'Callaghan, R M Califf
Circulation|December 13, 1997
Trials in myocardial infarctionE M Ohman, R M Califf, E J Topol
Clinical Pharmacology and Therapeutics|July 17, 2007
Role of the centers for education and research on therapeutics (CERTs) in pharmacovigilance and proper use of therapeuticsH H Tilson, L K Madre, R M Califf
Circulation|September 1, 1991
Clinical trials of restenosis after coronary angioplastyJ J Popma, R M Califf, E J Topol
Drugs|September 1, 1992
Thrombolytic therapy for acute myocardial infarction. A review C B Granger, R M Califf, E J Topol
The British Journal of Clinical Practice|November 1, 1993
The irony of biased editors who write editorials. GUSTO InvestigatorsE J Topol, R M Califf, K L Lee
Annals of Internal Medicine|June 1, 1994
The last word on GUSTO, for nowK L Lee, R M Califf, E J Topol
Journal of the American College of Cardiology|November 1, 1989
From myocardial salvage to patient salvage in acute myocardial infarction: the role of reperfusion therapyR M Califf, E J Topol, B J Gersh
Journal of the American College of Cardiology|April 12, 2000
Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery diseaseA M Lincoff, R M Califf, E J Topol
Circulation|November 1, 1990
Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trialsR M Califf, L Harrelson-Woodlief, E J Topol
Pageof 57